Cita APA

Tabernero Caturla, J., Velez, L., Trevino, T. L., Grothey, A., Van Cutsem, E., & Yaeger, R. (2021). Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: Insights from the BEACON CRC study.

Citación estilo Chicago

Tabernero Caturla, Josep, L. Velez, T. L. Trevino, Axel Grothey, Eric Van Cutsem, y Rona Yaeger. Management of Adverse Events From the Treatment of Encorafenib Plus Cetuximab for Patients With BRAF V600E-mutant Metastatic Colorectal Cancer: Insights From the BEACON CRC Study. 2021.

Cita MLA

Tabernero Caturla, Josep, et al. Management of Adverse Events From the Treatment of Encorafenib Plus Cetuximab for Patients With BRAF V600E-mutant Metastatic Colorectal Cancer: Insights From the BEACON CRC Study. 2021.